A citation-based method for searching scientific literature

Benedikt C Westphalen, Carsten Bokemeyer, Reinhard Büttner, Stefan Fröhling, Verena I Gaidzik, Hanno Glimm, Ulrich T Hacker, Volker Heinemann, Anna L Illert, Ulrich Keilholz, Thomas Kindler, Martin Kirschner, Bastian Schilling, Jens T Siveke, Thomas Schroeder, Verena Tischler, Sebastian Wagner, Wilko Weichert, Daniel Zips, Sonja Loges. Eur J Cancer 2020
Times Cited: 12







List of co-cited articles
43 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma.
Qiang Gao, Hongwen Zhu, Liangqing Dong, Weiwei Shi, Ran Chen, Zhijian Song, Chen Huang, Junqiang Li, Xiaowei Dong, Yanting Zhou,[...]. Cell 2019
244
8



Preanalytic Variables and Tissue Stewardship for Reliable Next-Generation Sequencing (NGS) Clinical Analysis.
Paolo A Ascierto, Carlo Bifulco, Giuseppe Palmieri, Solange Peters, Nikoletta Sidiropoulos. J Mol Diagn 2019
13
8

Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells.
Hui Liang, Qi-Li Zheng, Peng Fang, Jian Zhang, Tuo Zhang, Wei Liu, Min Guo, Christopher L Robinson, Shui-Bing Chen, Xiao-Ping Chen,[...]. Sci Rep 2017
37
8

Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe.
E J Blok, E Bastiaannet, W B van den Hout, G J Liefers, V T H B M Smit, J R Kroep, C J H van de Velde. Cancer Treat Rev 2018
40
8

Counting absolute numbers of molecules using unique molecular identifiers.
Teemu Kivioja, Anna Vähärautio, Kasper Karlsson, Martin Bonke, Martin Enge, Sten Linnarsson, Jussi Taipale. Nat Methods 2011
549
8

Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia.
Nicoletta Coccaro, Luisa Anelli, Antonella Zagaria, Paola Casieri, Giuseppina Tota, Paola Orsini, Luciana Impera, Angela Minervini, Crescenzio F Minervini, Cosimo Cumbo,[...]. J Mol Diagn 2018
24
8

Tracking the Evolution of Non-Small-Cell Lung Cancer.
Mariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, Nicolai J Birkbak, Thomas B K Watkins, Selvaraju Veeriah, Seema Shafi, Diana H Johnson, Richard Mitter, Rachel Rosenthal,[...]. N Engl J Med 2017
8

High-throughput single-cell gene-expression profiling with multiplexed error-robust fluorescence in situ hybridization.
Jeffrey R Moffitt, Junjie Hao, Guiping Wang, Kok Hao Chen, Hazen P Babcock, Xiaowei Zhuang. Proc Natl Acad Sci U S A 2016
191
8

Salmon provides fast and bias-aware quantification of transcript expression.
Rob Patro, Geet Duggal, Michael I Love, Rafael A Irizarry, Carl Kingsford. Nat Methods 2017
8

Pharmacoproteomic characterisation of human colon and rectal cancer.
Martin Frejno, Riccardo Zenezini Chiozzi, Mathias Wilhelm, Heiner Koch, Runsheng Zheng, Susan Klaeger, Benjamin Ruprecht, Chen Meng, Karl Kramer, Anna Jarzab,[...]. Mol Syst Biol 2017
22
8

A 10-Long Non-Coding RNA-Based Expression Signature as a Potential Biomarker for Prognosis of Acute Myeloid Leukemia.
Ping Tang, Menghan Xie, Yan Wei, Xinsheng Xie, Dandan Chen, Zhongxing Jiang. Med Sci Monit 2019
7
14

Genetic variation in human drug-related genes.
Charlotta Pauline Irmgard Schärfe, Roman Tremmel, Matthias Schwab, Oliver Kohlbacher, Debora Susan Marks. Genome Med 2017
58
8

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
D J Slamon, B Leyland-Jones, S Shak, H Fuchs, V Paton, A Bajamonde, T Fleming, W Eiermann, J Wolter, M Pegram,[...]. N Engl J Med 2001
8

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
Geffen Kleinstern, Nicola J Camp, Lynn R Goldin, Celine M Vachon, Claire M Vajdic, Silvia de Sanjose, J Brice Weinberg, Yolanda Benavente, Delphine Casabonne, Mark Liebow,[...]. Blood 2018
18
8

HGVS Recommendations for the Description of Sequence Variants: 2016 Update.
Johan T den Dunnen, Raymond Dalgleish, Donna R Maglott, Reece K Hart, Marc S Greenblatt, Jean McGowan-Jordan, Anne-Francoise Roux, Timothy Smith, Stylianos E Antonarakis, Peter E M Taschner. Hum Mutat 2016
768
8

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, A Pellagatti, J S Wainscoat, E Hellstrom-Lindberg, C Gambacorti-Passerini,[...]. N Engl J Med 2011
846
8

Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging.
Yury Goltsev, Nikolay Samusik, Julia Kennedy-Darling, Salil Bhate, Matthew Hale, Gustavo Vazquez, Sarah Black, Garry P Nolan. Cell 2018
393
8

Neoplastic cell percentage estimation in tissue samples for molecular oncology: recommendations from a modified Delphi study.
Kelly Dufraing, J Henricus van Krieken, Gert De Hertogh, Gerald Hoefler, Anca Oniscu, Tine P Kuhlmann, Wilko Weichert, Caterina Marchiò, Ari Ristimäki, Aleš Ryška,[...]. Histopathology 2019
9
11

The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?
Alexander Höllein, Sven O Twardziok, Wencke Walter, Stephan Hutter, Constance Baer, Jesus Maria Hernandez-Sanchez, Manja Meggendorfer, Torsten Haferlach, Wolfgang Kern, Claudia Haferlach. Cancer Genet 2020
14
8


Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh,[...]. N Engl J Med 2019
842
8

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
E Van Cutsem, A Cervantes, R Adam, A Sobrero, J H Van Krieken, D Aderka, E Aranda Aguilar, A Bardelli, A Benson, G Bodoky,[...]. Ann Oncol 2016
8

Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.
Filippo Pietrantonio, Rosalba Miceli, Alessandra Raimondi, Young Woo Kim, Won Ki Kang, Ruth E Langley, Yoon Young Choi, Kyoung-Mee Kim, Matthew Guy Nankivell, Federica Morano,[...]. J Clin Oncol 2019
128
8


ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.
Kai Wang, Mingyao Li, Hakon Hakonarson. Nucleic Acids Res 2010
8

Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
Bart Koopman, Harry J M Groen, Marjolijn J L Ligtenberg, Katrien Grünberg, Kim Monkhorst, Adrianus J de Langen, Mirjam C Boelens, Marthe S Paats, Jan H von der Thüsen, Winand N M Dinjens,[...]. Oncologist 2021
9
11

NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer.
Christoph Heining, Peter Horak, Sebastian Uhrig, Paula L Codo, Barbara Klink, Barbara Hutter, Martina Fröhlich, David Bonekamp, Daniela Richter, Katja Steiger,[...]. Cancer Discov 2018
98
8

Comprehensive Perspective for Lung Cancer Characterisation Based on AI Solutions Using CT Images.
Tania Pereira, Cláudia Freitas, José Luis Costa, Joana Morgado, Francisco Silva, Eduardo Negrão, Beatriz Flor de Lima, Miguel Correia da Silva, António J Madureira, Isabel Ramos,[...]. J Clin Med 2020
5
20

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
8

Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Alice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, D Ross Camidge, Benjamin J Solomon, Ravi Salgia, Gregory J Riely, Marileila Varella-Garcia, Geoffrey I Shapiro, Daniel B Costa,[...]. N Engl J Med 2014
8

Biomarker definitions and their applications.
Robert M Califf. Exp Biol Med (Maywood) 2018
245
8

The cancer biomarker problem.
Charles L Sawyers. Nature 2008
598
8

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Joaquin Mateo, Nuria Porta, Diletta Bianchini, Ursula McGovern, Tony Elliott, Robert Jones, Isabel Syndikus, Christy Ralph, Suneil Jain, Mohini Varughese,[...]. Lancet Oncol 2020
257
8

Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer.
Eri Sugiyama, Yosuke Togashi, Yoshiko Takeuchi, Sayoko Shinya, Yasuko Tada, Keisuke Kataoka, Kenta Tane, Eiichi Sato, Genichiro Ishii, Koichi Goto,[...]. Sci Immunol 2020
58
8

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein.
Yu Wang, Xiwei Ding, Shaoqing Wang, Catherine D Moser, Hassan M Shaleh, Essa A Mohamed, Roongruedee Chaiteerakij, Loretta K Allotey, Gang Chen, Katsuyuki Miyabe,[...]. Cancer Lett 2016
55
8

Beyond histology: translating tumor genotypes into clinically effective targeted therapies.
Catherine B Meador, Christine M Micheel, Mia A Levy, Christine M Lovly, Leora Horn, Jeremy L Warner, Douglas B Johnson, Zhongming Zhao, Ingrid A Anderson, Jeffrey A Sosman,[...]. Clin Cancer Res 2014
46
8

Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study.
W Victoria Lai, Louisiane Lebas, Tristan A Barnes, Julie Milia, Ai Ni, Oliver Gautschi, Solange Peters, Roberto Ferrara, Andrew J Plodkowski, John Kavanagh,[...]. Eur J Cancer 2019
51
8

Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.
Jinjia Chang, Xinyang Liu, Shanshan Wang, Zhe Zhang, Zheng Wu, Xiaowei Zhang, Jin Li. PLoS One 2014
42
8

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
P Therasse, S G Arbuck, E A Eisenhauer, J Wanders, R S Kaplan, L Rubinstein, J Verweij, M Van Glabbeke, A T van Oosterom, M C Christian,[...]. J Natl Cancer Inst 2000
8

Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
Matthias Preusser, Anna S Berghoff, Romina Koller, Christoph C Zielinski, Johannes A Hainfellner, Sandra Liebmann-Reindl, Niko Popitsch, Christoph B Geier, Berthold Streubel, Peter Birner. Eur J Cancer 2015
26
8

Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.
Johan Botling, Karolina Edlund, Miriam Lohr, Birte Hellwig, Lars Holmberg, Mats Lambe, Anders Berglund, Simon Ekman, Michael Bergqvist, Fredrik Pontén,[...]. Clin Cancer Res 2013
219
8

WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.
Jason J Luke, Riyue Bao, Randy F Sweis, Stefani Spranger, Thomas F Gajewski. Clin Cancer Res 2019
270
8

Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes.
Iva Gudernova, Iva Vesela, Lukas Balek, Marcela Buchtova, Hana Dosedelova, Michaela Kunova, Jakub Pivnicka, Iva Jelinkova, Lucie Roubalova, Alois Kozubik,[...]. Hum Mol Genet 2016
44
8

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.
Murry W Wynes, Trista K Hinz, Dexiang Gao, Michael Martini, Lindsay A Marek, Kathryn E Ware, Michael G Edwards, Diana Böhm, Sven Perner, Barbara A Helfrich,[...]. Clin Cancer Res 2014
129
8

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.
Jonathan Weiss, Martin L Sos, Danila Seidel, Martin Peifer, Thomas Zander, Johannes M Heuckmann, Roland T Ullrich, Roopika Menon, Sebastian Maier, Alex Soltermann,[...]. Sci Transl Med 2010
617
8

miRTarBase: a database curates experimentally validated microRNA-target interactions.
Sheng-Da Hsu, Feng-Mao Lin, Wei-Yun Wu, Chao Liang, Wei-Chih Huang, Wen-Ling Chan, Wen-Ting Tsai, Goun-Zhou Chen, Chia-Jung Lee, Chih-Min Chiu,[...]. Nucleic Acids Res 2011
847
8

Targeted therapy in non-small-cell lung cancer--is it becoming a reality?
Filip Janku, David J Stewart, Razelle Kurzrock. Nat Rev Clin Oncol 2010
202
8

Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
Linnéa La Fleur, Elin Falk-Sörqvist, Patrik Smeds, Anders Berglund, Magnus Sundström, Johanna Sm Mattsson, Eva Brandén, Hirsh Koyi, Johan Isaksson, Hans Brunnström,[...]. Lung Cancer 2019
75
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.